Want to see IN:MAXHEALTH full AI Analyst Report?
Max Healthcare Institute Ltd (MAXHEALTH) AI Stock Analysis
Max Healthcare Institute Ltd
(NSE:MAXHEALTH)
The score is anchored by solid financial performance driven by revenue scale-up and profitability, but it is materially held back by weak and volatile free-cash-flow generation and a sharp increase in debt in 2026. Technicals are bearish with price below major moving averages and negative MACD, and valuation is unattractive due to a high P/E with a very low dividend yield.
Max Healthcare Institute Ltd (MAXHEALTH) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 986.90B
- Dividend Yield
- 0.23%
- Average Volume (3M)
- 558.44K
- Price to Earnings (P/E)
- 57.4
- Beta (1Y)
- 1.03
- Revenue Growth
- 15.17%
- EPS Growth
- 1.63%
- Country
- India
- Employees
- 25,895
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Care Facilities
Max Healthcare Institute Ltd Business Overview & Revenue Model
Company Description
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmo...
How the Company Makes Money
Max Healthcare primarily generates revenue by delivering hospital-based healthcare services to patients. Key revenue streams typically include: (1) Inpatient services, where the company earns fees for bed occupancy and packaged/fee-for-service treatm...
Max Healthcare Institute Ltd Financial Statement Overview
Summary
Income statement strength (score 78) reflects meaningful revenue scale-up and solid operating profitability, but net margin has eased from 2023 highs and 2026 shows lower operating profit vs 2025. Balance sheet is generally healthy (score 70), though debt stepped up sharply in 2026, reducing flexibility. Cash flow is the key drag (score 52) due to volatile and recently weaker free cash flow and less-than-ideal cash conversion versus net income.
Income Statement
78PositiveBalance Sheet
70PositiveCash Flow
52Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 87.12B | 83.73B | 70.28B | 54.06B | 45.63B | 39.37B |
| Gross Profit | 49.17B | 65.83B | 43.77B | 33.53B | 28.31B | 21.89B |
| EBITDA | 23.96B | 23.57B | 18.87B | 15.20B | 12.56B | 9.79B |
| Net Income | 14.57B | 14.42B | 10.76B | 10.58B | 11.04B | 6.05B |
Balance Sheet | ||||||
| Total Assets | 0 | 172.31B | 152.14B | 120.00B | 101.02B | 91.89B |
| Cash, Cash Equivalents and Short-Term Investments | 6.66B | 7.71B | 6.82B | 9.80B | 13.74B | 4.81B |
| Total Debt | 0 | 34.78B | 30.10B | 13.05B | 6.89B | 11.33B |
| Total Liabilities | -107.47B | 64.84B | 58.34B | 35.92B | 26.92B | 29.07B |
| Stockholders Equity | 107.47B | 107.47B | 93.81B | 84.08B | 74.10B | 62.82B |
Cash Flow | ||||||
| Free Cash Flow | -413.10M | 1.49B | 4.94B | 3.36B | 8.74B | 1.87B |
| Operating Cash Flow | 8.18B | 16.33B | 14.59B | 11.22B | 12.09B | 7.48B |
| Investing Cash Flow | -9.66B | -16.89B | -16.32B | -12.85B | -11.87B | -7.72B |
| Financing Cash Flow | -353.20M | 592.70M | -1.64B | -2.64B | -2.89B | -2.94B |
Max Healthcare Institute Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MAXHEALTH, the sentiment is Negative. The current price of 860.00 is below the 20-day moving average (MA) of 862.16, below the 50-day MA of 953.29, and below the 200-day MA of 1012.84, indicating a bearish trend. The MACD of -35.30 indicates Negative momentum. The RSI at 38.97 is Neutral, neither overbought nor oversold. The STOCH value of 74.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MAXHEALTH.
Max Healthcare Institute Ltd Peers Comparison
Overall Rating
IN:ASTERDM73Outperform
IN:NH67Neutral
IN:APOLLOHOSP62Neutral
IN:MEDANTA60Neutral
IN:FORTIS59Neutral- IN:MAXHEALTH55.25Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| IN:ASTERDM | 73Outperform | INR 595.70B | 110.40 | ― | 0.59% | 15.70% | -2.76% |
| IN:NH | 67Neutral | INR 351.44B | 42.88 | ― | 0.26% | 71.40% | 1.76% |
| IN:APOLLOHOSP | 62Neutral | INR 1.21T | 58.13 | ― | 0.24% | 17.20% | 32.79% |
| IN:MEDANTA | 60Neutral | INR 341.22B | 61.37 | ― | 0.08% | 21.27% | 4.09% |
| IN:FORTIS | 59Neutral | INR 581.17B | 55.34 | ― | 0.13% | 17.50% | 20.65% |
| IN:MAXHEALTH | 55Neutral | INR 837.05B | 57.45 | ― | 0.23% | 15.17% | 1.63% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:MAXHEALTH | Max Healthcare Institute Ltd | 860.00 | -284.47 | -24.86% | |
| IN:APOLLOHOSP | Apollo Hospitals Enterprise Limited | 8400.00 | 594.57 | 7.62% | |
| IN:ASTERDM | Aster DM Healthcare Ltd. | 683.40 | 4.80 | 0.71% | |
| IN:FORTIS | Fortis Healthcare Ltd. | 769.80 | -259.46 | -25.21% | |
| IN:MEDANTA | Global Health Limited | 1269.05 | -6.25 | -0.49% | |
| IN:NH | Narayana Hrudayalaya Ltd. | 1719.70 | -62.04 | -3.48% |
Max Healthcare Institute Ltd Corporate Events
Max Healthcare updates on adjourned NCLT case involving Kalinga Hospital subsidiary
Max Healthcare Institute Ltd has updated exchanges on ongoing legal proceedings involving its subsidiary Kalinga Hospital Ltd and BRS Capital Two Pte. Limited, which has filed petitions before the National Company Law Tribunal’s Cuttack Bench o...
Max Healthcare Seeks Shareholder Nod on ESOP Scheme, MD Pay and MoA Change via E-Vote
Max Healthcare Institute Ltd has initiated a shareholder approval process via postal ballot, conducted exclusively through remote e-voting, in line with Indian company law, SEBI listing norms, and recent Ministry of Corporate Affairs circulars. The n...
Max Healthcare Seeks Shareholder Nod on RSU Plan, MD Pay and MoA Change via Postal Ballot
Max Healthcare Institute Limited has initiated a postal ballot process to seek shareholder approval via remote e-voting on several strategic resolutions, including a new performance-linked restricted stock unit (RSU) scheme for eligible employees. Th...
Max Healthcare to Engage Investors at Jefferies India Forum 2026
Max Healthcare Institute Ltd has announced that its representatives will participate in Jefferies’ 5th India Forum 2026, scheduled for September 16, 2026, at The Oberoi in Gurgaon. The participation will involve physical one-on-one and group in...
Max Healthcare to Engage Investors at J.P. Morgan India Conference 2026
Max Healthcare Institute Ltd, one of India’s leading listed healthcare providers, has announced its participation in the J.P. Morgan India Conference 2026, scheduled to be held physically at St. Regis, Mumbai. Representatives of the company wil...
Max Healthcare Updates NCLT Proceedings Involving Kalinga Hospital Subsidiary
Max Healthcare Institute Ltd is a major private hospital operator in India, providing tertiary and quaternary healthcare services through a network of facilities that includes subsidiaries such as Kalinga Hospital Ltd. The company focuses on deliveri...
Max Healthcare Shares Investor Presentation Ahead of Global Conference
Max Healthcare Institute Ltd, a major Indian hospital and healthcare services operator, runs multi-specialty facilities in key urban centres. The company is listed on the National Stock Exchange and BSE under the symbols MAXHEALTH and 543220, reflect...
Max Healthcare to Join Motilal Oswal Global Investor Conference in Mumbai
Max Healthcare Institute Ltd operates in India’s healthcare services industry, running a network of hospitals and related medical facilities with a focus on providing clinical care and allied health services to patients across key urban markets...
Max Healthcare Schedules Q1 FY27 Earnings Call for Investors
Max Healthcare Institute Limited has scheduled an earnings call for investors and analysts to discuss its financial results for the quarter ended June 30, 2026, with senior management leading the discussion. The call, set for August 14, 2026, will fo...
Max Healthcare Updates on NCLT Proceedings Involving Kalinga Hospital Subsidiary
Max Healthcare Institute Ltd has updated exchanges on ongoing legal proceedings involving its subsidiary Kalinga Hospital Ltd, stemming from petitions filed by legal representatives of BRS Capital Two Pte. Limited. The dispute relates to the acquisit...
Max Healthcare Files Minutes of 25th AGM with Indian Stock Exchanges
Max Healthcare Institute Limited convened its 25th Annual General Meeting on July 30, 2026, via video conference and other audio-visual means, with the deemed venue in Mumbai and participation from its board of directors and senior management. The co...
Max Healthcare Publishes Transcript of 25th AGM Held Via Video Conference
Max Healthcare Institute Ltd has released the transcript of its 25th Annual General Meeting, which was held on July 30, 2026 via video conference in compliance with Companies Act and SEBI listing regulations. The meeting, chaired by Managing Director...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 22, 2026